ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1092

Immune Complex-Driven Neutrophil Activation and BAFF Production Promote B Cell Activation and Autoantibody Production in Human SLE

Andrew Vasconcellos1, John Marken1, Sladjana Skopelja-Gardner1, Christian Lood2 and Natalia V. Giltiay1, 1Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, 2Division of Rheumatology, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: B cells, BAFF, NETosis, SLE and autoantibodies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The production of anti-nuclear auto-antibodies (Ab) and the formation of immune complexes (IC) are hallmarks of Systemic Lupus Erythematosus (SLE). Enhanced neutrophil (PMN) activation and formation of neutrophil extracellular traps (NETs), through engulfment of nucleic acid-containing ICs, have been implicated in disease pathogenesis, particularly in the acceleration of tissue inflammation, end-organ and vascular damage. Upon activation, PMNs may contribute to B cell activation and auto-Ab production by three main mechanisms: indirectly by NETs-stimulated interferon production, or directly, by releasing B cell activating factor (BAFF) and extruding autoantigens, such as mitochondria, during NETosis. Still, little is known about the link between the PMN activation and B cell immune responses in human SLE. This study was undertaken to test whether IC-driven PMN activation and NET formation contribute to BAFF increase, auto-Ab production and B cell activation in SLE patients.

Methods: BAFF levels were analyzed in serum samples from 60 SLE patients and 20 healthy controls (HC) by ELISA. Markers of neutrophil activation and NETosis (S100A8/A9, MPO-DNA complexes, cell-free oxidized (8-OHdG) DNA and mitochondrial (mt) DNA levels) were analyzed by ELISA, fluorimetric assays, and qPCR. FcγRIIA internalization, a bioassay for IC quantification, was analyzed by flow cytometry. Anti-DNA IgG titers, anti-cardiolipin (CP) IgM and IgG, C3 and C4 complement and CRP levels were obtained from clinical records. PMNs from healthy donors were stimulated with RNP-containing ICs and PMN activation, BAFF production, and B cell activation were studied in vitro.

Results: Levels of BAFF were markedly elevated in SLE as compared to HC serum samples (p< 0.0001). Consistent with our hypothesis of neutrophil-driven BAFF release in SLE, levels of BAFF correlated with markers of PMN activation (S100A8/A9) and NET-derived components, including mtDNA and cell-free 8-OHdG DNA (r=0.34-0.38, p<0.05 for both analyses). Increased BAFF levels associated significantly with decreased serum C3 and C4 levels, suggesting an association with ongoing IC-driven disease. Furthermore, levels of serum ICs correlated with an increase in BAFF levels (r=0.38, p=0.02) as determined by a flow cytometry-based bioassay. Auto-Ab analysis showed positive correlations between anti-DNA and anti-CL Ab titers, BAFF levels and markers of NETosis, including 8-OHdG DNA and S100A8/A9 levels. Stimulation of PMNs with ICs in vitro induced PMN activation, NET formation, and a significant increase in BAFF release three-to-six hours post-stimulation. PMN-B cell co-culture experiments showed increased B cell activation in response to IC-induced PMN activation.

Conclusion: Our results support the hypothesis that PMNs, through IC-mediated activation, release BAFF and auto-Ags, including DNA and mitochondrial components, which may contribute to B cell activation and production of pathogenic auto-Abs. These findings bring new insight into the mechanisms of PMN-B cell interactions involved in the pathogenesis of SLE.


Disclosure: A. Vasconcellos, None; J. Marken, None; S. Skopelja-Gardner, None; C. Lood, None; N. V. Giltiay, None.

To cite this abstract in AMA style:

Vasconcellos A, Marken J, Skopelja-Gardner S, Lood C, Giltiay NV. Immune Complex-Driven Neutrophil Activation and BAFF Production Promote B Cell Activation and Autoantibody Production in Human SLE [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/immune-complex-driven-neutrophil-activation-and-baff-production-promote-b-cell-activation-and-autoantibody-production-in-human-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-complex-driven-neutrophil-activation-and-baff-production-promote-b-cell-activation-and-autoantibody-production-in-human-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology